Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

10 Dec 2019 07:00

RNS Number : 3247W
Sensyne Health PLC
10 December 2019
 

 

 

Board Changes

 

Oxford, UK; 10 December 2019: Sensyne Health plc (LSE: SENS), the British clinical AI technology company, announces that Annalisa Jenkins and Andrew Gilbert stepped down from the Board of Sensyne yesterday. The Board has appointed Sir Bruce Keogh, Independent Non-Executive Director, as Interim Non-Executive Chair of the Board, effective immediately, whilst the search continues for an independent non-executive chair and additional independent non-executive directors. Spencer Stuart have been appointed to undertake the search on behalf of the Company.

 

Sir Bruce Keogh is the Chair of Birmingham Women's and Children's NHS Foundation Trust. He previously served as NHS Medical Director and Director General in the Department of Health from November 2007 to March 2013. Following the 2012 health service reforms he was appointed National Medical Director of NHS England from April 2013 to January 2018. During a decade as the most senior doctor in the NHS he had responsibility for national clinical policy and strategy.

 

Prior to joining the Department of Health, he had a distinguished international career as a cardiac surgeon, having first been a consultant at the Hammersmith Hospital in London, then University Hospital Birmingham before becoming Professor of Cardiac Surgery at UCL and Director of Surgery at the Heart Hospital.

 

As a result of these changes, Mary Hardy has been appointed as Senior Independent Director and Chair of the Nomination Committee.

 

Bruce Keogh, Chairman of Sensyne Health, said: "The Board would like to thank Annalisa and Andrew for their important and valuable contributions to the Company. We are now in the process of bolstering our Board and look forward to updating the market in due course."

 

-ENDS-

 

For more information please contact:

 

Sensyne Health (www.sensynehealth.com)

+44 (0) 330 058 1845

Lord (Paul) Drayson, Chief Executive Officer

Lorimer Headley, Chief Financial Officer

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+ 44 (0) 20 7418 8900

Dr Christopher Golden

James Steel

Oliver Jackson

 

 

Liberum (Joint Broker)

+ 44 (0) 20 3100 2000

Bidhi Bhoma

Euan Brown

Consilium Strategic Communications

+44 20 3709 5700

Mary-Jane Elliott

Sukaina Virji

Melissa Gardiner

sensynehealth@consilium-comms.com

 

 

 

About Sensyne Health

Sensyne Health plc is a clinical AI company that works in partnership with the NHS to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L). For more information, please visit: www.sensynehealth.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOACKKDQABDKKBD
Date   Source Headline
20th Jun 20227:00 amRNSCancellation - Sensyne Health plc
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:36 pmRNSPrice Monitoring Extension
15th Jun 20226:00 pmRNSSensyne Health
15th Jun 202211:00 amRNSPrice Monitoring Extension
14th Jun 20222:05 pmRNSSecond Price Monitoring Extn
14th Jun 20222:00 pmRNSPrice Monitoring Extension
14th Jun 202211:05 amRNSSecond Price Monitoring Extn
14th Jun 202211:00 amRNSPrice Monitoring Extension
14th Jun 20229:00 amRNSPrice Monitoring Extension
8th Jun 20224:40 pmRNSSecond Price Monitoring Extn
8th Jun 20224:35 pmRNSPrice Monitoring Extension
6th Jun 202212:46 pmRNSResults of General Meeting
19th May 202211:05 amRNSSecond Price Monitoring Extn
19th May 202211:00 amRNSPrice Monitoring Extension
18th May 20225:12 pmRNSPublication of circular, notice of general meeting
17th May 20222:06 pmRNSSecond Price Monitoring Extn
17th May 20222:00 pmRNSPrice Monitoring Extension
3rd May 20223:24 pmRNSHolding(s) in Company
28th Apr 20224:40 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
21st Apr 20222:05 pmRNSSecond Price Monitoring Extn
21st Apr 20222:00 pmRNSPrice Monitoring Extension
19th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
19th Apr 202211:05 amRNSSecond Price Monitoring Extn
19th Apr 202211:00 amRNSPrice Monitoring Extension
19th Apr 20229:53 amRNSForm 8.3 - Sensyne Health Plc
19th Apr 20228:54 amRNSForm 8.5 (EPT/RI)
19th Apr 20227:00 amRNSAmendments to Financing
14th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
14th Apr 20229:21 amRNSForm 8.5 (EPT/RI) - Sensyne Health PLC
13th Apr 20225:00 pmEQSForm 8.3 - Lupus alpha Asset Management AG: Sensyne Health PLC
13th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
13th Apr 20229:27 amRNSForm 8.5 (EPT/RI)
12th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
12th Apr 20228:31 amRNSForm 8.5 (EPT/RI)
12th Apr 20227:00 amRNSHoldings in Company
11th Apr 20222:00 pmRNSPrice Monitoring Extension
11th Apr 20221:36 pmRNSForm 8.3 - Sensyne Health plc
11th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
11th Apr 202210:34 amRNSForm 8.3 - Sensyne Health plc
11th Apr 20229:34 amRNSForm 8.5 (EPT/RI) - Sensyne Health PLC
11th Apr 20229:07 amRNSForm 8.3 - Sensyne Health Plc
8th Apr 20224:41 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
8th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
8th Apr 20229:05 amRNSSecond Price Monitoring Extn
8th Apr 20229:00 amRNSPrice Monitoring Extension
8th Apr 20227:00 amRNSBoard Change and Updates on Financing and FSP
7th Apr 20221:23 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.